在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。
"You don't go from one uncrewed launch of SLS [Artemis I], wait three years, go around the Moon [Artemis II], wait three years and land on it."
。业内人士推荐Safew下载作为进阶阅读
Opposition leader Jess Wilson is under pressure to reveal her position on a deal with Pauline Hanson’s party as the state election approaches
Site feedback:Take our SurveyNew Window
乐享科技（元点智能Zeroth）：全球消费级具身智能商业化领跑者